Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell S Cairo

Showing results (111-120 of 298) with videos related to

Pageof 30
Sort By:
American Journal of Clinical Pathology|September 9, 2005
TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphomaMichael A Teitell, Mark A Lones, Sherrie L Perkins, et al.
Transfusion|June 7, 2005
Results of the cord blood transplantation (COBLT) study unrelated donor banking programJoanne Kurtzberg, Mitchell S Cairo, John K Fraser, et al.
Pediatric Blood & Cancer|October 27, 2004
Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experiencePatrick Van Winkle, Anne Angiolillo, Mark Krailo, et al.
Pediatric Blood & Cancer|July 12, 2008
Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology GroupKristi J Smock, Marilu Nelson, Sheryl R Tripp, et al.
Cytotherapy|May 27, 2014
Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicityPrakash Satwani, Sejal Bavishi, Aniket Saha, et al.
Cancer Immunology Research|December 11, 2014
Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG MiceYaya Chu, Jessica Hochberg, Ashlin Yahr, et al.
Oncotarget|March 9, 2018
Ruxolitinib significantly enhances <i>in vitro</i> apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine modelSanghoon Lee, Tishi Shah, Changhong Yin, et al.
Oncotarget|May 19, 2018
Pre-clinical activity of targeting the PI3K/Akt/mTOR pathway in Burkitt lymphomaMaria Bhatti, Thomas Ippolito, Cory Mavis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2011
Risk factors associated with kidney injury and the impact of kidney injury on overall survival in pediatric recipients following allogeneic stem cell transplantPrakash Satwani, Sejal Bavishi, Zhezhen Jin, et al.
Experimental Hematology|October 22, 2016
Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapyJanet Ayello, Jessica Hochberg, Allyson Flower, et al.
Pageof 30

Showing results (111-120 of 298) with videos related to

Sort By:
Pageof 30
American Journal of Clinical Pathology|September 9, 2005
TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphomaMichael A Teitell, Mark A Lones, Sherrie L Perkins, et al.
Transfusion|June 7, 2005
Results of the cord blood transplantation (COBLT) study unrelated donor banking programJoanne Kurtzberg, Mitchell S Cairo, John K Fraser, et al.
Pediatric Blood & Cancer|October 27, 2004
Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experiencePatrick Van Winkle, Anne Angiolillo, Mark Krailo, et al.
Pediatric Blood & Cancer|July 12, 2008
Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology GroupKristi J Smock, Marilu Nelson, Sheryl R Tripp, et al.
Cytotherapy|May 27, 2014
Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicityPrakash Satwani, Sejal Bavishi, Aniket Saha, et al.
Cancer Immunology Research|December 11, 2014
Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG MiceYaya Chu, Jessica Hochberg, Ashlin Yahr, et al.
Oncotarget|March 9, 2018
Ruxolitinib significantly enhances <i>in vitro</i> apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine modelSanghoon Lee, Tishi Shah, Changhong Yin, et al.
Oncotarget|May 19, 2018
Pre-clinical activity of targeting the PI3K/Akt/mTOR pathway in Burkitt lymphomaMaria Bhatti, Thomas Ippolito, Cory Mavis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2011
Risk factors associated with kidney injury and the impact of kidney injury on overall survival in pediatric recipients following allogeneic stem cell transplantPrakash Satwani, Sejal Bavishi, Zhezhen Jin, et al.
Experimental Hematology|October 22, 2016
Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapyJanet Ayello, Jessica Hochberg, Allyson Flower, et al.
Pageof 30